(S (NP (NP (DT The) (NN evaluation)) (PP (IN of) (NP (JJ white) (NN matter) (NN lesion) (NN progression)))) (VP (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN biomarker)) (PP (IN in) (NP (NP (DT the) (NN follow-up)) (PP (IN of) (NP (NNP MS) (NNS patients))))))) (CC and) (VP (VBZ plays) (NP (DT a) (JJ crucial) (NN role)) (SBAR (WHADVP (WRB when)) (S (VP (VBG deciding) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NN treatment))))))))) (. .))
(S (NP (NNP Current) (VBD automated) (NN lesion) (NN segmentation) (NN algorithms)) (VP (VBP are) (ADJP (JJ susceptible) (PP (TO to) (NP (NP (NN variability)) (PP (IN in) (NP (NN image) (NNS characteristics))) (VP (VBN related) (PP (TO to) (NP (NNP MRI) (NN scanner) (CC or) (NN protocol) (NNS differences)))))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (NP (NP (DT a) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ improves) (NP (NP (DT the) (NN consistency)) (PP (IN of) (NP (NNP MS) (NN lesion) (NNS segmentations))) (PP (IN in) (NP (JJ inter-scanner) (NNS studies))))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBP train) (S (NP (DT a) (NNP CNN) (NN base) (NN model)) (VP (TO to) (VP (VB approximate) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NP (NN icobrain)) (, ,) (NP (DT an) (NNP FDA-approved) (ADJP (NN clinically) (JJ available)) (NN lesion) (NN segmentation) (NN software))))))))) (. .))
(S (NP (DT A) (NN discriminator) (NN model)) (VP (VBZ is) (ADVP (RB then)) (VP (VBN trained) (S (VP (TO to) (VP (VB predict) (SBAR (SBAR (IN if) (S (NP (CD two) (NN lesion) (NNS segmentations)) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (NP (NNS scans)) (VP (VBN acquired) (S (VP (VBG using) (NP (DT the) (JJ same) (NN scanner) (NN type))))))))))) (CC or) (RB not))))) (, ,) (S (VP (VBG achieving) (NP (NP (DT a) (ADJP (CD 78) (NN %)) (NN accuracy)) (PP (IN in) (NP (DT this) (NN task)))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (NP (DT the) (NN base) (NN model)) (CC and) (NP (DT the) (NN discriminator))) (VP (VBP are) (VP (VBN trained) (ADVP (RB adversarially)) (PP (IN on) (NP (JJ multi-scanner) (JJ longitudinal) (NNS data))) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (JJ inter-scanner) (NN consistency)) (PP (IN of) (NP (DT the) (NN base) (NN model))))))))) (. .))
(S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (NNS models)))) (VP (VBZ is) (VP (VBN evaluated) (PP (IN on) (NP (NP (DT an) (JJ unseen) (NN dataset)) (VP (VBG containing) (NP (JJ manual) (NNS delineations))))))) (. .))
(S (NP (DT The) (JJ inter-scanner) (NN variability)) (VP (VBZ is) (VP (VBN evaluated) (PP (IN on) (NP (NP (JJ test-retest) (NNS data)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (JJ adversarial) (NN network)) (VP (VBZ produces) (NP (NP (JJ improved) (NNS results)) (PP (IN over) (NP (NP (DT the) (NN base) (NN model)) (CC and) (NP (DT the) (JJ FDA-approved) (NN solution)))))))))))) (. .))
